Articles

Potential Alzheimer’s drug further backs protein hypothesis

The results of an experimental drug for Alzheimer’s disease provide the best evidence so far that the memory-robbing condition is caused by an errant protein in the brain. Drugmakers including Eli Lilly have been concentrating their Alzheimer’s research on that area.

Read More
Simon Breaking

Macerich rejects Simon Property’s $22.4B takeover bid

California-based mall owner Macerich Co. has rebuffed an unsolicited takeover bid from Simon Property Group Inc., saying it substantially undervalues the company and raises antitrust concerns. Analysts and investors expect Simon will make a higher bid.

Read More

Macerich investors want more to clinch mall megadeal

Simon’s acquisition offer is only 6.6 percent higher than Macerich’s average price in the previous 20 days. One reason the premium looks miniscule is because Macerich’s stock had already jumped 24 percent since November on takeover speculation fanned by Simon.

Read More
Simon Headquarters

Macerich, Simon shares rise on talk of acquisition

Macerich Co. shares had their biggest increase in three months Thursday morning after the Wall Street Journal reported that Simon Property Group Inc., the largest U.S. mall owner, has made approaches to buy the company.

Read More
Simon HQ

Simon interested in acquiring West Coast mall owner

Simon Property Group Inc. has approached Santa Monica, California-based Macerich Co. about an acquisition after taking a stake in the company last year, sources say. Macerich, with a market value of $13.3 billion, has a high concentration of West Coast properties.

Read More